Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses

As the prevalence of Alzheimer disease (AD) continues to rise unabated, new models have been put forth to improve our understanding of this devastating condition. Although individual models may have their merits, integrated models may prove more valuable. Indeed, the reliable failures of monotherapi...

Full description

Bibliographic Details
Main Authors: Nicholas G. Norwitz, Adrian Soto Mota, Sam G. Norwitz, Kieran Clarke
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Aging Neuroscience
Subjects:
tau
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2019.00184/full
id doaj-bc96562e586f4b84bcf6c3e652e5e2e6
record_format Article
spelling doaj-bc96562e586f4b84bcf6c3e652e5e2e62020-11-25T00:47:58ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652019-07-011110.3389/fnagi.2019.00184471688Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes HypothesesNicholas G. Norwitz0Adrian Soto Mota1Sam G. Norwitz2Kieran Clarke3Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United KingdomDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United KingdomDepartment of Neuroscience, Washington University in St. Louis, St. Louis, MO, United StatesDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United KingdomAs the prevalence of Alzheimer disease (AD) continues to rise unabated, new models have been put forth to improve our understanding of this devastating condition. Although individual models may have their merits, integrated models may prove more valuable. Indeed, the reliable failures of monotherapies for AD, and the ensuing surrender of major drug companies, suggests that an integrated perspective may be necessary if we are to invent multifaceted treatments that could ultimately prove more successful. In this review article, we discuss the Wnt/Glycogen Synthase Kinase 3β (GSK3β), α-synuclein, and type 3 diabetes hypotheses of AD, and their deep interconnection, in order to foster the integrative thinking that may be required to reach a solution for the coming neurological epidemic.https://www.frontiersin.org/article/10.3389/fnagi.2019.00184/fullAlzheimer diseaseAβα-synucleinGSK3βParkinson’s diseasetau
collection DOAJ
language English
format Article
sources DOAJ
author Nicholas G. Norwitz
Adrian Soto Mota
Sam G. Norwitz
Kieran Clarke
spellingShingle Nicholas G. Norwitz
Adrian Soto Mota
Sam G. Norwitz
Kieran Clarke
Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses
Frontiers in Aging Neuroscience
Alzheimer disease

α-synuclein
GSK3β
Parkinson’s disease
tau
author_facet Nicholas G. Norwitz
Adrian Soto Mota
Sam G. Norwitz
Kieran Clarke
author_sort Nicholas G. Norwitz
title Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses
title_short Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses
title_full Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses
title_fullStr Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses
title_full_unstemmed Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses
title_sort multi-loop model of alzheimer disease: an integrated perspective on the wnt/gsk3β, α-synuclein, and type 3 diabetes hypotheses
publisher Frontiers Media S.A.
series Frontiers in Aging Neuroscience
issn 1663-4365
publishDate 2019-07-01
description As the prevalence of Alzheimer disease (AD) continues to rise unabated, new models have been put forth to improve our understanding of this devastating condition. Although individual models may have their merits, integrated models may prove more valuable. Indeed, the reliable failures of monotherapies for AD, and the ensuing surrender of major drug companies, suggests that an integrated perspective may be necessary if we are to invent multifaceted treatments that could ultimately prove more successful. In this review article, we discuss the Wnt/Glycogen Synthase Kinase 3β (GSK3β), α-synuclein, and type 3 diabetes hypotheses of AD, and their deep interconnection, in order to foster the integrative thinking that may be required to reach a solution for the coming neurological epidemic.
topic Alzheimer disease

α-synuclein
GSK3β
Parkinson’s disease
tau
url https://www.frontiersin.org/article/10.3389/fnagi.2019.00184/full
work_keys_str_mv AT nicholasgnorwitz multiloopmodelofalzheimerdiseaseanintegratedperspectiveonthewntgsk3basynucleinandtype3diabeteshypotheses
AT adriansotomota multiloopmodelofalzheimerdiseaseanintegratedperspectiveonthewntgsk3basynucleinandtype3diabeteshypotheses
AT samgnorwitz multiloopmodelofalzheimerdiseaseanintegratedperspectiveonthewntgsk3basynucleinandtype3diabeteshypotheses
AT kieranclarke multiloopmodelofalzheimerdiseaseanintegratedperspectiveonthewntgsk3basynucleinandtype3diabeteshypotheses
_version_ 1725257552468377600